Navigation Links
Personalized Stem Cells, Inc. Announces First Patients Treated in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
Date:11/14/2019

Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, has successfully enrolled the first patients in an FDA approved clinical trial for stem cell treatment of knee osteoarthritis. The first treatment came shortly after the one-year anniversary of the formation of the company as a subsidiary of VetStem Biopharma.

In July of 2019, PSC received FDA approval for a New Drug (IND) application to conduct clinical trials for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. This first clinical trial uses stem cells to treat osteoarthritis in the knee.

PSC has recruited, trained, and qualified clinical trial sites sufficient to treat up to 125 patients in this first clinical trial. Clinical trial sites are currently located in San Diego and Los Angeles California, Portland Oregon, Chicago Illinois, and New Jersey. Additional clinical trial sites are anticipated in coming months.

PSC CEO, Michael Dale, stated, “We are pleased with the response from patients who suffer from knee arthritis and with the diligence and enthusiasm of the participating clinics around the country. We expect to rapidly increase enrollment in this first clinical trial as we prepare for additional clinical trials using stem cells for orthopedic injuries.”

This is the first of several planned clinical trials which will enable qualified PSC-enrolled physicians to provide FDA compliant, quality cell therapy to patients suffering from osteoarthritis. PSC plans to conduct a series of FDA approved clinical trials starting with uses in orthopedics and expanding to other medical conditions such as trauma in the future.

PSC is working within the FDA cell therapy regulations to provide stem cell therapy for patients that follows the rules FDA has created in order to assure consistent manufacturing, quality tested cells and clinical trial and manufacturing oversite for safety and efficacy.

PSC was founded by Michael Dale, CEO, and Robert Harman, DVM, MPVM, Chief Scientific Officer, both of whom also co-founded VetStem Biopharma and are both experienced serial entrepreneurs.

About Personalized Stem Cells, Inc.
Personalized Stem Cells was formed in 2018 to advance and legitimize human regenerative medicine. This privately held biopharmaceutical enterprise, based near San Diego (California), offers qualified physicians who enroll, an FDA compliant autologous stem cell product (from patient’s own fat tissue) for use in FDA approved clinical trials. PSC is driving development and adoption of stem cell and regenerative medicine within the FDA-IND process by providing cGMP manufactured, quality tested cells, and well-defined clinical trials. PSC has licensed a portfolio of over 70 issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/personalized_stem_cells_inc_announces_first_patients_treated_in_fda_approved_clinical_trial_for_treatment_of_osteoarthritis_with_stem_cells/prweb16717272.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Personalized Stem Cells, Inc. Announces First Patients Enrolled in FDA Approved Clinical Trial for Treatment of Osteoarthritis with Stem Cells
2. VetStem Biopharma Secures FDA Approval of First Human IND for its Subsidiary, Personalized Stem Cells, Inc.
3. Personalized Stem Cells, Inc. Announces FDA Approval of IND Application for Treatment of Osteoarthritis with Stem Cells
4. Personalized Medicine: A New Approach to Treat Periodontal Diseases
5. Zipongo Incorporates 23andMe Reports Into Personalized Nutrition Plans
6. Personalized Medicine - Scientific and Commercial Aspects - 318 Companies Profiled with 575 Collaborations - Research and Markets
7. NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology
8. @USANAincs Personalized Nutrition Program Wins Industry Innovation Award
9. "Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014
10. Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers
11. Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2019)... (PRWEB) , ... November 07, 2019 , ... R3 Stem ... 50% off through the rest of 2019. The code to use during checkout is ... well. , R3 is the nation’s leader in regenerative therapies with over 12,000 successful ...
(Date:11/5/2019)... ... 2019 , ... Dr. Lauren Kopp celebrates one year ... WA, including porcelain veneers , smile makeovers, dental implants, and the Bioclear ... Dr. Kopp is passionate about serving her Seattle community with empathy and precision ...
(Date:10/30/2019)... ... October 30, 2019 , ... PathSensors, ... in Nashville, TN from Tuesday, November 5, 2019, to Thursday, November 7, 2019. ... biological, radiological, nuclear) and IED (explosive) threats. Delegates and experts from over 30 ...
Breaking Biology News(10 mins):
(Date:11/2/2019)... ... October 31, 2019 , ... A clinical ... with each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs ... not informed of the latest data, potentially leading to patient risk. , By ...
(Date:10/30/2019)... CITY, S.D. (PRWEB) , ... October 30, 2019 , ... ... team of researchers and students at South Dakota School of Mines & Technology ... cancer cells while leaving healthy cells alive. , If successful, the technique would ...
(Date:10/29/2019)... ... October 29, 2019 , ... Modality ... Silver sponsorship and cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) ... Diego, California. , The Biomanufacturing World Summit brings together pharmaceutical executives, ...
(Date:10/22/2019)... ANGELES (PRWEB) , ... October 22, 2019 , ... nQ ... Graziadio Business School’s 2019 Most Fundable Companies List which was announced at a showcase ... than $10 million in annual revenue, strong business plans, and impressive near-term growth projections ...
Breaking Biology Technology: